DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
There is no evidence that paclitaxel-coated devices used for the treatment of femoropopliteal artery disease increases the long-term risk of death when compared with an uncoated balloon or stent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback